156 related articles for article (PubMed ID: 12122113)
1. Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor.
Chazenbalk GD; Pichurin P; Chen CR; Latrofa F; Johnstone AP; McLachlan SM; Rapoport B
J Clin Invest; 2002 Jul; 110(2):209-17. PubMed ID: 12122113
[TBL] [Abstract][Full Text] [Related]
2. A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity.
Li Y; Kim J; Diana T; Klasen R; Olivo PD; Kahaly GJ
Clin Exp Immunol; 2013 Sep; 173(3):390-7. PubMed ID: 23647395
[TBL] [Abstract][Full Text] [Related]
3. Studies in mice deficient for the autoimmune regulator (Aire) and transgenic for the thyrotropin receptor reveal a role for Aire in tolerance for thyroid autoantigens.
Misharin AV; Nagayama Y; Aliesky HA; Rapoport B; McLachlan SM
Endocrinology; 2009 Jun; 150(6):2948-56. PubMed ID: 19264867
[TBL] [Abstract][Full Text] [Related]
4. Development and basic performance verification of a rapid homogeneous bioassay for agonistic antibodies against the thyroid-stimulating hormone receptor.
Hoshina M; Ojima S; Kawasaki A; Doi K; Ohta S; Inoue A; Murayama H
J Immunol Methods; 2024 May; 528():113655. PubMed ID: 38447802
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody mimicry of hormone action at the thyrotropin receptor.
Faust B; Billesbølle CB; Suomivuori CM; Singh I; Zhang K; Hoppe N; Pinto AFM; Diedrich JK; Muftuoglu Y; Szkudlinski MW; Saghatelian A; Dror RO; Cheng Y; Manglik A
Nature; 2022 Sep; 609(7928):846-853. PubMed ID: 35940205
[TBL] [Abstract][Full Text] [Related]
6. Withdrawn: TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.
Rapoport B; McLachlan SM
Endocr Rev; 2016 Feb; 2016(1):23-42. PubMed ID: 27454362
[TBL] [Abstract][Full Text] [Related]
7. Practical applications of studies on the TSH receptor and TSH receptor autoantibodies.
Furmaniak J; Sanders J; Sanders P; Miller-Gallacher J; Ryder MM; Rees Smith B
Endocrine; 2020 May; 68(2):261-264. PubMed ID: 32472423
[TBL] [Abstract][Full Text] [Related]
8. Novel Antimurine Thyroid-Stimulating Hormone Receptor Monoclonal Antibodies.
Klee AN; Torchia JA; Freeman GJ
Monoclon Antib Immunodiagn Immunother; 2023 Jun; 42(3):109-114. PubMed ID: 37343169
[TBL] [Abstract][Full Text] [Related]
9. Thyrotropin receptor autoantibody (TRAb) enhance the expression of thyrotropin receptor on mouse brain vascular endothelial cells: in vivo and in vitro.
Liang C; Yang H; Huang X; Kuang Y; Deng X; Liu Y; Luo Z
Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):67-74. PubMed ID: 37807332
[TBL] [Abstract][Full Text] [Related]
10. Long term persistence of thyrotropin receptor antibodies in wild-type and transgenic mice in a Graves' disease model.
McLachlan SM; Aliesky H; Chen CR; Rapoport B
Thyroid; 2012 Apr; ():. PubMed ID: 22489908
[TBL] [Abstract][Full Text] [Related]
11. Expression and Purification of the Human Thyroid-Stimulating Hormone Receptor.
Helfinger L; Tate CG
Methods Mol Biol; 2022; 2507():313-325. PubMed ID: 35773589
[TBL] [Abstract][Full Text] [Related]
12. Neoself Antigens Presented on MHC Class II Molecules in Autoimmune Diseases.
Jin H; Arase H
Adv Exp Med Biol; 2024; 1444():51-65. PubMed ID: 38467972
[TBL] [Abstract][Full Text] [Related]
13. Hyperthyroidism and Wnt Signaling Pathway: Influence on Bone Remodeling.
Mudri D; Bilić Ćurčić I; Meštrović L; Mihaljević I; Kizivat T
Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837860
[TBL] [Abstract][Full Text] [Related]
14. Unexpected Crosslinking Effects of a Human Thyroid Stimulating Monoclonal Autoantibody, M22, with IGF1 on Adipogenesis in 3T3L-1 Cells.
Umetsu A; Sato T; Watanabe M; Ida Y; Furuhashi M; Tsugeno Y; Ohguro H
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674625
[TBL] [Abstract][Full Text] [Related]
15. Structure of full-length TSH receptor in complex with antibody K1-70™.
Núñez Miguel R; Sanders P; Allen L; Evans M; Holly M; Johnson W; Sullivan A; Sanders J; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2023 Jan; 70(1):. PubMed ID: 36069797
[TBL] [Abstract][Full Text] [Related]
16. Abrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules.
Jin H; Kishida K; Arase N; Matsuoka S; Nakai W; Kohyama M; Suenaga T; Yamamoto K; Sasazuki T; Arase H
Sci Adv; 2022 Mar; 8(9):eabj9867. PubMed ID: 35245125
[TBL] [Abstract][Full Text] [Related]
17. Elevated activity levels of activating autoantibodies to the GnRH receptor in patients with polycystic ovary syndrome.
Weedin EA; Burks HR; Yu X; Li HL; Aston CE; Kem DC; Craig LB
F S Rep; 2020 Dec; 1(3):299-304. PubMed ID: 34223260
[TBL] [Abstract][Full Text] [Related]
18. Graves' disease.
Davies TF; Andersen S; Latif R; Nagayama Y; Barbesino G; Brito M; Eckstein AK; Stagnaro-Green A; Kahaly GJ
Nat Rev Dis Primers; 2020 Jul; 6(1):52. PubMed ID: 32616746
[TBL] [Abstract][Full Text] [Related]
19. A Novel Method to Identify Autoantibodies against Putative Target Proteins in Serum from beta-Thalassemia Major: A Pilot Study.
Sumera A; Anuar ND; Radhakrishnan AK; Ibrahim H; Rutt NH; Ismail NH; Tan TM; Baba AA
Biomedicines; 2020 Apr; 8(5):. PubMed ID: 32357536
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
